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 Complete assessment of the GerontoNet ADR Risk Score and 
condensed BADRI model was performed in 1075 older in-patients 
 Median age was 81.4 ± 7.4 years 
 Overall, 41 patients (3.8%) experienced at least one ADR during 
hospital stay that was definitely or probably caused by drug use  
 Both ADR risk screening tools had low accuracy scores for 
predicting ADRs and there was no significant difference in their 
discriminating performance (P = 0.891) 
 Cut-off values >1 and >3 were recommended with development of 
the BADRI model and GerontoNet ADR Risk Score, respectively. Our 
Youden’s Index was largest with cut-off value >1 for the BADRI 
model (Se = 66%, Sp = 59%) and >6 for the GerontoNet ADR Risk 
Score (Se = 46%, Sp = 78%) 
COMPARISON OF TWO TOOLS TO ASSESS RISK OF  
ADVERSE DRUG REACTIONS IN OLDER IN-PATIENTS 
Adverse drug reactions (ADRs) are common in 
hospital setting, especially in older patients. Both the 
GerontoNet ADR risk score and the Brighton ADRs 
Risk (BADRI) model are clinical tools which aim to 
identify those older patients at risk of developing an 
ADR during hospital stay.  
The objective of this study was to evaluate and 
compare these ADR risk screening tools in terms of 
their ability to predict ADRs in hospitalized older 
patients. 
 CRiteria to assess appropriate Medication use among Elderly complex patients 
(CRIME) project 
 Older patients, consecutively admitted to geriatric and internal medicine acute 
care wards of seven Italian hospitals (N = 1123)  
 The GerontoNet ADR risk score (range 0 – 10) includes variables on ≥4 
comorbid conditions, heart failure, liver disease, number of drugs, previous 
ADR, and renal failure 
 The BADRI model (range 0 – 5) includes variables on ≥8 drugs, hyperlipidemia, 
raised white cell count, use of anti-diabetic agents, and length of stay ≥12 days. 
A condensed BADRI score (range 0 – 4; without raised white cell count) was 
used 
 ADRs with definite or probable causality with drug use (defined according to 
the Naranjo algorithm) were considered 
Neither the GerontoNet ADR risk score, nor the 
BADRI model performs to a sufficiently high 
level of discrimination efficacy for ADRs.  
Further research could determine additional 
ADR risk factors to extend and improve these 
ADR risk screening tools. 
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Survival Curves for Sarcopenia and Frailty States in Community-Dwelling Older Belgian Men (N=191), predicted from age-adjusted Cox regression models.  
